Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine Doses for Hypotension in Cesarean Section
NCT05993182Phase 4Completed
- Sponsor
- Aswan University
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ephedrine in hypotension (3 arms), sponsored by Aswan University. Primary endpoint: Survival analysis or time until an event occurs. Started Aug 2023; status: completed.
02
Drugs
ephedrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05993182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05993182.